Cessation of long-acting β2-agonist in children with persistent asthma on inhaled corticosteroids

被引：3
|
作者：
Ducharme, Francine M. [1 ,2 ,3 ]
Gagnon, Roxanne [2 ]
Benard, Brigitte [2 ]
Tse, Sze Man [1 ,2 ]
Thivierge, Robert [1 ]
机构：
[1] Univ Montreal, Dept Pediat, Montreal, PQ, Canada
[2] CHU St Justine, Res Ctr, Clin Res & Knowledge Translat Unit Childhood Asth, Montreal, PQ, Canada
[3] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷 / 02期
关键词：
CANADIAN THORACIC SOCIETY; PRESCHOOLERS; MANAGEMENT; DIAGNOSIS;
D O I：
10.1183/13993003.00014-2016
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：558 / 560
页数：3
相关论文
共 50 条
  • [21] Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma
    O'Byrne, Paul M.
    van der Linde, Just
    Cockcroft, Donald W.
    Gauvreau, Gail M.
    Brannan, John D.
    FitzGerald, Mark
    Watson, Richard M.
    Milot, Joanne
    Davis, Beth
    O'Connor, Megan
    Hart, Lorna
    Korducki, Lawrence
    Hamilton, Alan L.
    Boulet, Louis-Philippe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (06) : 1217 - 1221
  • [22] Combination therapy with a long-acting β2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma -: Response
    Murray, J
    Dorinsky, P
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (03) : 411 - 412
  • [23] Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
    Price, David
    Bousquet, Jean
    RESPIRATORY MEDICINE, 2012, 106 : S4 - S8
  • [24] SAFETY AND TOLERABILITY OF MOMETASONE FUROATE/FORMOTEROL FOR PERSISTENT ASTHMA SUBJECTS WHO PREVIOUSLY WERE TREATED WITH MEDIUM-DOSE INHALED CORTICOSTEROIDS (ALONE OR WITH A LONG-ACTING β2-AGONIST)
    Nathan, R.
    Pearlman, D.
    Nolte, H.
    Nayak, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A58 - A58
  • [25] Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma
    Xia, Ying
    Kelton, Christina M. L.
    Xue, Liang
    Guo, Jeff J.
    Bian, Boyang
    Wigle, Patricia R.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2013, 4 (06) : 254 - 263
  • [26] Real-world effects of two inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
    Yatera, Kazuhiro
    Yamasaki, Kei
    Nishida, Chinatsu
    Noguchi, Shingo
    Oda, Keishi
    Akata, Kentarou
    Nagata, Shuya
    Kawanami, Yukiko
    Kawanami, Toshinori
    Ishimoto, Hiroshi
    Mukae, Hiroshi
    JOURNAL OF ASTHMA, 2014, 51 (07) : 762 - 768
  • [27] Indacaterol: A Novel Long-Acting β2-Agonist
    Ray, Shaunta' M.
    McMillen, James C.
    Treadway, Sarah A.
    Helmer, Robert S.
    Franks, Andrea S.
    PHARMACOTHERAPY, 2012, 32 (05): : 456 - 474
  • [28] Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children
    Chauhan, Bhupendrasinh F.
    Chartrand, Caroline
    Chroinin, Muireann Ni
    Milan, Stephen J.
    Ducharme, Francine M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [29] Long-acting beta 2-agonist use in South African children
    Green, Robin J.
    Lewis, Humphrey
    Ossip, Mervyn
    SOUTH AFRICAN JOURNAL OF CHILD HEALTH, 2007, 1 (01) : 40 - 40
  • [30] The long-acting β2-agonist salmeterol xinafoate:: effects on airway inflammation in asthma
    Roberts, JA
    Bradding, P
    Britten, KM
    Walls, AF
    Wilson, S
    Gratziou, C
    Holgate, ST
    Howarth, PH
    EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (02) : 275 - 282
12345